New drug AG-181 passes first safety check in healthy volunteers
NCT ID NCT06286033
First seen Nov 01, 2025 · Last updated Jun 05, 2026 · Updated 33 times
Summary
This early-stage study tested the safety and tolerability of a new drug called AG-181 in 88 healthy adults. Participants received either single or multiple doses of the drug or a placebo. The goal was to see how the body processes the drug and whether it causes any side effects. This research is a first step before testing the drug in people with a specific disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON 1255 East 3900 South
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.